ENTITY
GSK

GSK (GSK US)

29
Analysis
Health CareUnited States
GSK PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GSK provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
more
bullishGSK
30 Sep 2024 17:00

GlaxoSmithKline plc: Will Its Enhanced Focus on Immunotherapy and Oncology Yield Dividends? - Major Drivers

GSK has reported a strong performance for its second quarter of the year, with a 13% increase in sales to GBP 7.9 billion. Highlighting the...

Logo
205 Views
Share
bullishGSK
09 Aug 2024 13:00

GlaxoSmithKline plc: Enhancing Market Position with AREXVY and Other Major Brands! - Major Drivers

GSK's recent quarterly report underlines a robust upward trajectory with significant growth figures, showcasing the strength and diversity of its...

Logo
95 Views
Share
31 Oct 2024 07:00

Indegene Lockup Expiry - US$1bn+ Lockup Release, Some Could Look to Book 3x Gain

Indegene Limited (1864095D IN) was listed in India on 13th May 2024 after raising US$221m. Its six-month lockup will expire on 5th Nov 2024.

Logo
147 Views
Share
bullishGSK
26 Jun 2024 03:00

GlaxoSmithKline plc (GSK): What Is The Development In Terms Of Pipeline Development & Recent Technological Advancements? - Major Drivers

GSK has reported a robust start to the year with notable growth in both sales and profits, driven by strong execution and successful product...

Logo
241 Views
Share
bullishGSK
13 May 2024 22:00

GlaxoSmithKline plc: Will Its Ongoing Investment In Oncology & Vaccines Pay Off? - Major Drivers

GlaxoSmithKline demonstrated robust quarterly performance, continuing its commitment to creating long-term value for its stakeholders. The company...

Logo
189 Views
Share
x